Described are peptides and compounds that bind to and activate the thrombopoietin receptor. Such peptides and compounds are useful in methods for treating haematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labelled peptides and compounds.
申请公布号
CA2274149(C)
申请公布日期
2008.07.15
申请号
CA19972274149
申请日期
1997.12.09
申请人
GLAXO GROUP LIMITED
发明人
PODDUTURI, SUREKHA;GATES, CHRISTIAN M.;DOWER, WILLIAM J.;BARRETT, RONALD W.;CWIRLA, STEVEN E.;WAGSTROM, CHRISTOPHER R.;HENDREN, RICHARD WAYNE;YIN, QUN;DEPRINCE, RANDOLPH B.;SCHATZ, PETER J.;BALASUBRAMANIAN, PALANIAPPAN